pharma is the sole category represented across all 1 tracked stories. Merck & Co. (MSD) is most often covered alongside HPV, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Merck & Co. (MSD), all published on March 9, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Merck & Co. (MSD)
pharma is the sole category represented across all 1 tracked stories. Merck & Co. (MSD) is most often covered alongside HPV, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Merck & Co. (MSD), all published on March 9, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Merck & Co. (MSD). Shared-story counts are live from our verified record — not editorial picks.
A Hatfield-based clinic is launching a targeted weekend vaccination initiative as part of a broader NHS Hertfordshire campaign to increase HPV immunization rates among young adults. The program specifically targets individuals under 25 to close immunity gaps and support long-term cancer prevention goals.
Merck & Co. (MSD) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.